Article Versions Notes

Godefroy N, Junot H, Drieux-Rouzet L, Méloni C, Luyt C-E, Robert J, Bleibtreu A. Clostridioides difficile Infection Rates after Ceftolozane–Tazobactam and Ceftazidime–Avibactam Treatment Compared to Carbapenem Treatment: A Retrospective Single-Center Study. Hygiene. 2021; 1(3):99-105. https://doi.org/10.3390/hygiene1030009

Godefroy, Nagisa, Helga Junot, Laurence Drieux-Rouzet, Cyril Méloni, Charles-Edouard Luyt, Jérôme Robert, and Alexandre Bleibtreu. 2021. "Clostridioides difficile Infection Rates after Ceftolozane–Tazobactam and Ceftazidime–Avibactam Treatment Compared to Carbapenem Treatment: A Retrospective Single-Center Study" Hygiene 1, no. 3: 99-105. https://doi.org/10.3390/hygiene1030009

Godefroy, N., Junot, H., Drieux-Rouzet, L., Méloni, C., Luyt, C.-E., Robert, J., & Bleibtreu, A. (2021). Clostridioides difficile Infection Rates after Ceftolozane–Tazobactam and Ceftazidime–Avibactam Treatment Compared to Carbapenem Treatment: A Retrospective Single-Center Study. Hygiene, 1(3), 99-105. https://doi.org/10.3390/hygiene1030009